IMC Chicago’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.02M Sell
114,200
-101,300
-47% -$2.97M ﹤0.01% 2211
2025
Q4
$6.24M Buy
215,500
+25,400
+13% +$762K ﹤0.01% 1569
2025
Q3
$5.28M Sell
190,100
-40,800
-18% -$1.03M ﹤0.01% 1530
2025
Q2
$5.62M Sell
230,900
-14,900
-6% -$326K ﹤0.01% 1318
2025
Q1
$5.1M Buy
245,800
+17,500
+8% +$440K ﹤0.01% 1220
2024
Q4
$5.38M Buy
228,300
+4,200
+2% +$103K ﹤0.01% 1191
2024
Q3
$5.74M Sell
224,100
-42,900
-16% -$1.09M ﹤0.01% 1072
2024
Q2
$6.27M Buy
267,000
+38,100
+17% +$962K ﹤0.01% 967
2024
Q1
$6.58M Sell
228,900
-66,200
-22% -$1.99M ﹤0.01% 864
2023
Q4
$9.68M Buy
295,100
+258,700
+711% +$7.03M 0.01% 658
2023
Q3
$1.01M Sell
36,400
-14,400
-28% -$471K ﹤0.01% 1221
2023
Q2
$1.73M Sell
50,800
-29,600
-37% -$930K ﹤0.01% 926
2023
Q1
$2.42M Buy
80,400
+24,700
+44% +$765K ﹤0.01% 802
2022
Q4
$1.57M Sell
55,700
-27,600
-33% -$876K ﹤0.01% 889
2022
Q3
$2.74M Sell
83,300
-19,100
-19% -$701K ﹤0.01% 685
2022
Q2
$3.23M Sell
102,400
-87,700
-46% -$3.07M ﹤0.01% 613
2022
Q1
$8.73M Sell
190,100
-39,500
-17% -$1.88M 0.01% 483
2021
Q4
$14.1M Buy
229,600
+89,000
+63% +$6.15M 0.01% 428
2021
Q3
$10.5M Buy
140,600
+10,800
+8% +$906K 0.01% 482
2021
Q2
$12M Sell
129,800
-72,000
-36% -$6.12M 0.01% 420
2021
Q1
$17.9M Buy
+201,800
New +$20M 0.03% 317

Other funds holding ARKG

IMC Chicago's ARKG Position: Q4 2025 in Review

IMC Chicago sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 31,004 shares — an estimated $931K sold.

IMC Chicago first reported a position in ARKG in Q1 2021 and held it in 8 quarters. The position peaked at $1.96M in Q2 2025. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • IMC Chicago reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 31,004 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $931K.
  • IMC Chicago first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 8 quarters.
  • IMC Chicago's ARK Genomic Revolution ETF position peaked at $1.96M in Q2 2025.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.